Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Tuberous Sclerosis × ganaxolone × Clear all

Phase

Phase 3 2 Phase 2 1

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2

Interventions

ganaxolone 2 Sirolimus 2 Everolimus 2 Melatonin 1 Cannabidiol 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05604170 2025-10-01

Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy

Marinus Pharmaceuticals

Phase 3 Terminated

117 enrolled 11 charts

Tuberous Sclerosis

NCT05323734 2025-07-11

Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy

Marinus Pharmaceuticals

Phase 3 Completed

129 enrolled 13 charts

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡